PepGen Inc (PEPG)
17.25
-0.23
(-1.32%)
USD |
NASDAQ |
Jun 14, 16:00
17.31
+0.06
(+0.35%)
After-Hours: 20:00
PepGen Cash from Operations (Quarterly): -22.53M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -22.53M |
| December 31, 2023 | -19.42M |
| September 30, 2023 | -16.48M |
| June 30, 2023 | -17.68M |
| March 31, 2023 | -15.42M |
| December 31, 2022 | -13.39M |
| September 30, 2022 | -20.97M |
| Date | Value |
|---|---|
| June 30, 2022 | -12.64M |
| March 31, 2022 | -12.27M |
| December 31, 2021 | -5.986M |
| September 30, 2021 | -7.648M |
| June 30, 2021 | -6.135M |
| March 31, 2021 | -2.83M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-22.53M
Minimum
Mar 2024
-2.83M
Maximum
Mar 2021
-13.34M
Average
-13.39M
Median
Dec 2022
Cash from Operations (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 31.92M |
| Vertex Pharmaceuticals Inc | 1.307B |
| Sarepta Therapeutics Inc | -242.08M |
| PTC Therapeutics Inc | 70.76M |
| Regenxbio Inc | -55.46M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -11.29M |
| Cash from Financing (Quarterly) | 86.97M |
| Free Cash Flow | -77.58M |
| Free Cash Flow Per Share (Quarterly) | -0.7881 |
| Free Cash Flow Yield | -17.98% |